Repeated immunostaining of the same tissue section using alkaline phosphatase as a reporter

Area of Science:

• Immunohistochemistry
• Cellular and Molecular Biology
• Biotechnology

Background:

• Optimizing primary antibody concentration is critical for reliable immunohistochemistry (IHC) results.
• Standard IHC protocols often require extensive titration to find the best antibody dilution.
• Sequential staining on a single tissue section can reduce reagent usage but requires specific optimization.

Purpose of the Study:

• To develop and validate a method for determining optimal primary antibody concentrations in immunohistochemistry using sequential staining.
• To assess the impact of sequential incubation on optimal antibody concentration compared to single-run staining.
• To evaluate a novel method for removing residual alkaline phosphatase activity between sequential antibody incubations.

Main Methods:

• Sequential incubation of increasing primary antibody concentrations on the same tissue section.
• Utilizing alkaline phosphatase (AP) conjugated secondary antibodies as reporters.
• Implementing a denaturation and extraction step (80°C in 4:1 diglyme:PBS) to remove residual AP activity between tests.
• Testing the method with multiple primary antibodies (EMA, α-SMA, vimentin) and various chromogens.

Main Results:

• Optimal primary antibody concentrations for sequential staining were significantly lower than for single-run staining.
• Sequential staining with AP reporter required approximately one-fourth the primary antibody concentration compared to single-run staining.
• The denaturation and extraction method effectively removed residual AP activity, enabling accurate sequential testing.
• The method was validated across different primary antibodies and chromogens.

Conclusions:

• Sequential staining on a single tissue section is an efficient method for optimizing primary antibody concentrations in IHC.
• This approach significantly reduces the amount of primary antibody required, leading to cost savings.
• The developed protocol, including the denaturation step, provides a reliable way to determine optimal antibody dilutions for multiplex IHC applications.